AB vs SLM

The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score, raising concerns about bankruptcy risk assessment. Despite a high dividend yield of 8.73%, the payout ratio of 111.92% is unsustainable, supported by negative profit margin and declining revenue. Valuation appears stretched relative to intrinsic metrics, with the stock trading at $38.96 versus a Graham Number of $29.35 and intrinsic value of $20.72. Negative insider sentiment, deteriorating growth trends, and weak technicals further reinforce a bearish outlook.

SLM presents a stark contradiction between explosive growth and deteriorating financial health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is fundamentally undervalued with a P/E of 6.54 and trades below its Graham Number of $29.32, the low health score and bearish technical trend (0/100) suggest a potential value trap. Exceptional YoY earnings growth of 126.20% is offset by a high Debt/Equity ratio of 2.40 and a poor recent track record of earnings surprises. The discrepancy between the current price and the growth-based intrinsic value ($102.07) reflects significant market skepticism regarding the sustainability of its current trajectory.